GLP-1 Medications are Changing the Landscape of Cardiovascular Care
Event Ended- Where
- Reh-Fit Centre - 1390 Taylor Avenue, Winnipeg, Manitoba View Map
- When
- Price
- Free Buy Tickets
- Ages
- 18 - 80
- Website
- https://www.reh-fit.com/health-programs/smart-for-your-heart
- Contact
- sheldon.appelle@reh-fit.com (204) 488-5852 (Sheldon Appelle)
Pharmacist Tony Sacco will examine the emerging evidence on GLP (Glucagon-Like Peptide-1) receptor agonists and their role in lowering cardiovascular risk, enhancing metabolic health, and aiding long-term heart protection. This session will cover: How GLP-1 medications affect cardiovascular pathways, reduce major events, impact blood pressure, cholesterol, inflammation, and endothelial health. Important for people with heart disease, diabetes, or obesity. Clinicians learn about long-term cardiac protection. Emerging research in cardiometabolic medicine.